Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Mathematics provides tools for explanation and analysis in the physical, engineering, business and social sciences. These tools can help in areas as diverse as planning and evaluating market research, ...

Looking for ways to make some extra money this year? We've compiled a list of different passive income ideas to spark inspiration, including investing, real estate and a few niche options, like ...

Scientists at Novosibirsk State University (NSU) have developed an innovative approach to the accelerated creation of thermally activated delayed fluorescence (TADF) materials, which can lead to ...